Clincosm LogoSign in Get a demo

chronic myelogenous leukemia

Showing 51 - 75 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in United States (procedure, drug,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +25 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +5 more
Dec 17, 2019

Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)

Terminated
Has Results
  • Acute Leukemias
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Dec 12, 2019

Chronic Myelogenous Leukemia Trial (Pegylated interferon alfa-2b, Interferon alfa-2b)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • Pegylated interferon alfa-2b
  • Interferon alfa-2b
  • (no location specified)
Jul 12, 2019

Chronic Myelogenous Leukemia Trial in Lyon (Nilotinib,Novartis,300 mg twice a day +Pegylated interferon 2a,Roche, 45 microg

Completed
  • Chronic Myelogenous Leukemia
  • Nilotinib,Novartis,300 mg twice a day +Pegylated interferon 2a,Roche, 45 microg weekly starting Month 2-Month 12 or beyond according to investigator choice.
  • Lyon, France
    Hospices Civils de Lyon
May 23, 2019

Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

Completed
Has Results
  • Acute Leukemia
  • +8 more
  • Tacrolimus (ARM with Methotrexate)
  • +7 more
  • Duarte, California
  • +29 more
Jan 2, 2019

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (iTreg)

Completed
  • Acute Myelogenous Leukemia
  • +7 more
  • iTreg
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 17, 2019

Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma Trial in Richmond (biological, radiation, procedure, drug)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +7 more
  • Thymoglobulin
  • +4 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Nov 7, 2018

Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

Completed
Has Results
  • Acute Myeloid Leukemia
  • +10 more
  • Chicago, Illinois
    University of Illinois at Chicago Medical Center
Oct 9, 2018

Chronic Myelogenous Leukemia Trial in Houston (Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelogenous Leukemia
  • Lonafarnib (SCH66336)
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    M.D. Anderson Cancer Center
Nov 6, 2018

Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Leukemia Trial in Atlanta (Dasatinib, Imatinib Mesylate, Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Nov 1, 2018

Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial (Dendritic Cell Activated Lymphocyte)

Withdrawn
  • Acute Myelogenous Leukemia
  • Chronic Myelogenous Leukemia
  • Dendritic Cell Activated Lymphocyte
  • (no location specified)
Oct 24, 2018

Chronic Myelogenous Leukemia Trial in Boston (Arsenic trioxide)

Terminated
  • Chronic Myelogenous Leukemia
  • Arsenic trioxide
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 4, 2018

Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Burkitt Lymphoma Trial in Winston-Salem (cefepime HCl)

Completed
  • Adult Acute Lymphoblastic Leukemia
  • +38 more
  • cefepime hydrochloride
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 16, 2018

Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial run by the NHLBI (Stem Cell

Completed
  • Myelodysplastic Syndrome (MDS)
  • +4 more
  • Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +4 more
  • Allogeneic stem cell transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2018

Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

Completed
  • Chronic Myelogenous Leukemia
  • Hematologic Malignancies
  • San Francisco, California
  • +4 more
May 15, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Chronic Myelogenous Leukemia Trial in China (Compound realgar natural indigo Tablet, )

Suspended
  • Chronic Myelogenous Leukemia
  • Compound realgar natural indigo Tablet
  • placebo
  • Wuhan, Hubei, China
  • +12 more
Apr 23, 2018

Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia Trial in Hershey (Clofar, Cyclophos, Alemtuzumab, Clofar,

Terminated
Has Results
  • Leukemia
  • +5 more
  • Clofar, Cyclophos, Alemtuzumab
  • Clofar, Cyclophos,Alemtuzumab(Ph II)
  • Hershey, Pennsylvania
    Penn State College of Medicine, Penn State Milton S. Hershey Med
Mar 23, 2018

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,

Terminated
  • Myelodysplastic Syndrome
  • +9 more
  • Phoenix, Arizona
  • +6 more
Feb 13, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Minneapolis (90Y-AHN-12)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • 90Y-AHN-12
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (Unmanipulated UCB, SR-1

Withdrawn
  • Acute Myeloid Leukemia
  • +3 more
  • Unmanipulated UCB
  • SR-1 UCB
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Dec 3, 2017